Morgan Stanley Maintains Equal-Weight on Ovintiv, Raises Price Target to $49
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Devin McDermott has maintained an Equal-Weight rating on Ovintiv (NYSE:OVV) and increased the price target from $48 to $49.
March 28, 2024 | 6:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Ovintiv but raised the price target from $48 to $49.
The increase in price target by Morgan Stanley suggests a positive outlook on Ovintiv's future performance, potentially leading to increased investor confidence and a short-term positive impact on the stock price. The Equal-Weight rating indicates that the stock is expected to perform in line with the market or sector, but the raised target price signals specific optimism about Ovintiv's prospects.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90